R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Company profile
Ticker
RCM
Exchange
Website
CEO
Joseph Gerard Flanagan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Terminix Global • Mantech International • Gartner • Premier • Franklin Covey • Jupai • Evolent Health • Veritec • Phi • Global Tech Industries ...
Former names
PROJECT ROADRUNNER PARENT INC.
SEC CIK
Corporate docs
Subsidiaries
Accretive Health Mauritius, Inc. • Acustream, LLC • AS Buyer, Inc. • cGate Health, Inc. • Clearsight Intermediate Holdings, Inc. • CloudMed LLC • Cloudmed Blocker Parent, LLC • Cloudmed Holdings • Cloudmed Solutions, LLC • Data Bound Solutions LLC ...
IRS number
20698101
RCM stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-K
2022 FY
Annual report
16 Feb 23
8-K
R1 RCM Reports Fourth Quarter and Full Year 2022 Results
16 Feb 23
8-K
R1 RCM Announces Leadership Appointments; Reaffirms 2022 Guidance and Announces 2023 Outlook
5 Jan 23
8-K
Departure of Directors or Certain Officers
22 Dec 22
8-K
Departure of Directors or Certain Officers
14 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
R1 RCM Reports Third Quarter 2022 Results
8 Nov 22
8-K
Entry into a Material Definitive Agreement
12 Sep 22
424B7
Prospectus with selling stockholder info
12 Sep 22
FWP
Free writing prospectus
8 Sep 22
Latest ownership filings
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 110.10 mm | 110.10 mm | 110.10 mm | |||
Cash burn (monthly) | 7.00 mm | 10.97 mm | (no burn) | |||
Cash used (since last report) | 19.78 mm | 30.99 mm | n/a | |||
Cash remaining | 90.32 mm | 79.11 mm | n/a | |||
Runway (months of cash) | 12.9 | 7.2 | n/a |
Institutional ownership, Q4 2022
13F holders | Current |
---|---|
Total holders | 231 |
Opened positions | 58 |
Closed positions | 68 |
Increased positions | 98 |
Reduced positions | 53 |
13F shares | Current |
---|---|
Total value | 2.66 tn |
Total shares | 554.85 mm |
Total puts | 106.50 k |
Total calls | 1.71 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
TCP-ASC ACHI Series LLLP | 164.75 mm | $3.65 bn |
Mountain Investments V, L.L.C. New | 135.93 mm | $2.72 bn |
New Mountain Capital, L.L.C. | 94.41 mm | $917.58 bn |
BLK Blackrock | 17.82 mm | $195.15 bn |
Citadel Advisors | 11.76 mm | $128.77 bn |
Vanguard | 11.26 mm | $123.31 bn |
FMR | 10.99 mm | $120.30 bn |
Point72 Asset Management | 10.82 mm | $118.47 bn |
Sachem Head Capital Management | 6.79 mm | $74.35 bn |
BK Bank Of New York Mellon | 5.70 mm | $62.42 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Feb 23 | Lee Rivas | Common Stock | Buy | Acquire P | No | No | 13.934 | 71,767 | 1.00 mm | 71,767 |
16 Feb 23 | Richard B. Jr. Evans | Common Stock | Payment of exercise | Dispose F | No | No | 14.57 | 14,253 | 207.67 k | 142,878 |
16 Feb 23 | Richard B. Jr. Evans | Common Stock | Grant | Acquire A | No | No | 0 | 31,255 | 0.00 | 157,131 |
16 Feb 23 | Flanagan Joseph Gerard | Common Stock | Payment of exercise | Dispose F | No | No | 14.57 | 360,340 | 5.25 mm | 3,269,405 |
16 Feb 23 | Flanagan Joseph Gerard | Common Stock | Grant | Acquire A | No | No | 0 | 837,524 | 0.00 | 3,629,745 |
16 Feb 23 | John M. Sparby | Common Stock | Payment of exercise | Dispose F | No | No | 14.57 | 52,485 | 764.71 k | 214,773 |
16 Feb 23 | John M. Sparby | Common Stock | Grant | Acquire A | No | No | 0 | 143,486 | 0.00 | 267,258 |
News
$4.5M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
22 Feb 23
Canaccord Genuity Maintains Buy on R1 RCM, Raises Price Target to $21
17 Feb 23
R1 RCM Adj Q4 EPS $(0.09) Misses $(0.05) Estimate, Sales $532.80M Beat $519.21M Estimate
16 Feb 23
Earnings Scheduled For February 16, 2023
16 Feb 23
R1 RCM Earnings Preview
15 Feb 23
Press releases
R1 RCM Issues 2022 Environmental, Social, and Governance Report
1 Mar 23
R1 RCM to Present at Upcoming Investor Conferences
21 Feb 23
R1 RCM & Cloudmed Ranked #1 by KLAS in Multiple Categories for 2023
8 Feb 23
R1 RCM to Release Fourth Quarter 2022 Results on February 16
26 Jan 23
R1 RCM Announces Leadership Appointments; Reaffirms 2022 Guidance and Announces 2023 Outlook
5 Jan 23